ArticleToxicological research2025
Sodium benzoate exposure from juvenile to peripubertal period disrupts HPG-axis in both male and female rats.
Article in Toxicological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sodium benzoate (SB) is a synthetic preservative that is widely used in the food and pharmaceutical industries. Despite its antibacterial and fungal static properties, it can impair reproduction. However, its toxicity has not been fully studied during the sensitive developmental period in mammals. This study was aimed at examining the adverse effects of SB during the developmental period, particularly the HPG-axis. Thirty male and 30 female weanling rats (PND 21) were administered oral doses of SB (10-1000 mg/kg/BW) until the peripubertal period, whereas control animals were administered only distilled water. Body weight, reproductive organ weight, oxidants, antioxidants, and reproductive hormones were measured. Kisspeptin (hypothalamic peptide) regulates the HPG-axis by activating GnRH secretion and was assessed by immunohistochemistry using specific primary and secondary antibodies. Morphometric and histopathological analyses were performed on hematoxylin- and eosin-stained sections to assess reproductive organ damage. The experimental groups showed a significant reduction in body as well as reproductive organ weight. Higher reactive oxygen species (ROS) and TBARS levels were observed, accompanied by reduced antioxidant enzyme activities, such as SOD, POD, CAT, and GSH in the treatment groups. Furthermore, a hormonal analysis revealed a dose-dependent decrease in estradiol, testosterone, and FSH levels, whereas an increase in LH was noted in animals that were administered SB. A dose-dependent decrease in kisspeptin expression was observed in male and female treatment groups. Morphometric analysis revealed a significant decrease in the ovarian and testicular volumes. In addition, apparent cytoarchitectural alterations in both the testis and ovary were noticed, signifying profound structural damage to the gonadal tissue because of SB exposure. Our findings suggest that developmental exposure to SB causes serious structural and molecular changes in the HPG axis. These abnormalities over the critical developmental window may lead to disruption in the maturation of the reproductive system, which could be attributed to compromised reproductive health in adults. Supplementary Information: The online version contains supplementary material available at 10.1007/s43188-025-00286-z.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.